I am at a loss both mentally and financially about the goings on here.

The company is involved in health care and all it's peers have risen substantially.

Debt has been cleared, profits are rising and the chairman's statement was incredibly positive. I always thought a star of this kind would rise. Low market value etc etc. Any ideas why I'm apparently wrong?

MACD about to cross over and MA RSI is oversold we should see the SP move NORTH - IMO

Surgical innovates in the US

View Gallery
By Eric Barkas City Editor
Medical devices company Surgical Innovations is raising 4m before expenses via a share placing so it can develop its businesses.

Of the net sum raised, about 1.25m will be used as working capital for the Leeds-based company's US operations.

In December Surgical announced it had made inroads into the US market with an agreement to supply its YelloPort abdominal access system to one of America's biggest hospital groups.

Surgical is best known for devices used in laparoscopic surgery - a less invasive, keyhole, technique than conventional surgery. It produces the instruments and the access ports through which they are introduced into the body.

The company said yesterday that in the US, where 1.5m general laparoscopic surgery cases were performed last year, it had established relationships with major suppliers who would incorporate YelloPort in their customer offer.

Another 1.8m of the placing money will be used in the sales channels to deliver Surgical products to North American and European markets. That means developing existing product licences and winning new licences in markets where purchasing procedures are varied and differing marketing strategies are required.

Some 750,000 is earmarked for product development.

Surgical says its products have been well received South Africa as well as the US. Patents have been filed on the technology that is the basis for one new product.

Further funding is said to be needed for products as well as putting the necessary manufacturing capability in place.

yes but i dont agree with lining the pockets of the directors and advisors - whats wrong with an open offer to all shareholders including ones like me who has seen it all over the last 15 years!!!!!!!!!!!!!!!!!!

True..

On way back up?
Should be...considering
New business with GE Inspection Technologies for the inspection of large frame gas turbines.
Development contract with Gyrus ACMI for the design of a novel,handheld instrument now looking at upcoming commercialisation shortly.
and
Yelloport successful in supplying to the US Air Force base in North East Italy with possibilities of business with other worldwide US military bases.

Looking Good MA MACD crossing and crossed over.. RSI is oversold ...

IMO we should be moving North

LOOKING EVEN BETTER NOW !!!

Nar1, yess v good news & hopefully a climb in the 4th quarter of the year. on the watch list !

Nice bit of news on a day when the sun actually is shining in North Wales!

US Distribution Agreement



Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of
innovative surgical devices, announces that it has signed a distribution
agreement with MGM Med Inc. ('MGM'), a wholesale distributor of medical and
hospital equipment, for the provision of its laparoscopic equipment to the US
market.



Under the terms of the agreement, MGM has the right to use the Surgical
Innovations ('SI') name and will promote the SI brand through its newly formed
subsidiary, Surgical Innovations US Inc. ('Surgical US').



Surgical US will become the master distributor of SI branded products in the US
and will engage with new key channel partners including surgical procedural tray
companies, major medical distributors and small independent representatives that
service more than 6,000 hospitals in the US market



The agreement incorporates a minimum sales target of US$20 million, net to SI,
over the five year term.



The agreement has already led to the appointment by Surgical US of its first
channel partner, Tri-anim Health Services, Inc. ('Tri-anim'), a leading
specialty distributor of medical and hospital equipment in the US. Tri-anim
will begin sales of SI's single use laparoscopic scissors from August 2007,
initially in the south east of the US and increasing thereafter on a regional
basis, eventually providing nationwide coverage.

Mary Meyer, President and CEO of Surgical US, said: 'The US market for single
use scissors is currently valued at over US$125 million and we see huge
potential for SI products throughout the entire US laparoscopic equipment
market.'



Graham Bowland, Finance Director of Surgical Innovations Group plc, commented:
'The creation by MGM of Surgical US provides new and exciting routes to market
for SI's products, further expanding our presence within North America. The use
of the Surgical Innovations trademark will increase our brand recognition across
the US and will support our strategy for future growth.'

MACD - crossed over and some very good news !!

but needs the market to stay positive for a while otherwise the sp is likely to drop back

did market stay positive then ?? Still don't know what to do with Surgical shares...

Down at the moment ..... time to top up if you want ??

Hello. Anyone got any news on the upcoming interims? I haven't been able to find out how the new USA deal is going

Article in Yorkshire Post

"RESPOSABLE" is one of the words on the lips of Surgical Innovations finance director Graham Bowland. It's how the surgical devices company describes instruments that mix both re-usable and disposable components.
Leeds-based Surgical says such devices are proving to be more cost-effective than their fully disposable counterparts and, by focusing on them, the company is gaining a competitive edge.

Trademark is the other word Mr Bowland is keen to emphasise as Surgical seeks to both patent its devices and register them. The devices are for laparoscopic keyhole surgery.

The company is focusing more on developing, making and selling its own branded products.

Losing a big contract with Aesculap for surgical scissors showed the importance of the company's own brand compared with work for other manufacturers.

So, Surgical decided to invest more on designing its own products and was less concerned in design work for others. The upshot in half-year figures out yesterday was a fall in revenue to 1.9m from 2.1m and in pre-tax profit to 118,000 from 182,000.

Chairman Doug Liversidge says revenue lost with Aesculap is being replaced at a better margin by own-branded products, adding: "I'm now very comfortable with the position of the business."

Not that Surgical has given up its work for other manufacturers. Indeed, it has restructured itself into three trading companies, one of which, Core Precision, is dedicated to surgical and industrial solutions for such manufacturers.

The company has for some time been working with Rolls-Royce to supply "keyhole" devices to repair aero engines without the need to take the engines apart. It is also working with GE on devices to repair gas turbines and with Gyrus on gynaecology instruments.

In the blood business Haemocell, which enables patients to give their own blood rather than risk infection from donors, Surgical is looking for an international partner.

The biggest demand for Haemocell technology is from regions like the Far East, Middle East and from Russia, Mr Bowland says, so it makes sense to go into partnership.

The group structure should provide more focus for the individual businesses, Mr Liversidge says.

The core Surgical Innovations business has seen a lot of action lately. Much work has gone into the new YelloPort + Plus resposable device. The port is the access to the body for instruments, helping guide them to their target.

The new device combines re-usable main elements and disposable accessories.

In the last nine months the company has broken into the US market. First it signed a deal to supply YelloPort to one of the largest US hospital groups, North Shore Long Island Jewish Health System. Then it agreed a distribution deal with MGM Med, giving it access to the broad market.

The company is in effect licensing its brand to MGM, which is setting up a subsidiary called Surgical Innovations US.

That was seen as crucial, since many hospitals want to buy through US dealerships.

After years of disapointments we have yet more.
I though things were looking up from a SP point of view - clearly not.
The city does not look impressed.

Transco would you hold or sell? Is it worth waiting for another news or hoping that there is going to be some next contract to pump price up???

To be honest I w=have written them off.
The city clearly have no confidence in the management and I see the SP stagnating again.
Very very disapointing.

If you have a substantial holding worth anything I would sell and leave well alone in future.

"written off" not sure about that I have faith in the company and I have been topping at lower prices. Not only to lower by breakeven but also I believe in this company long term and therefore increasing my holding.

DYOR but I think this is cheap at this price, main thing for me its making money and feel my money is safe long term this will make me a nice profit.....

Well no one else seems to agree - look at the sp it tells everything!!